A new antibody drug demonstrated similar efficacy to currently available therapies to treat advanced ERBB2-positive breast cancer, according to a recent clinical trial.
Browsing: Clinical Breakthroughs
A new anti-obesity medication is almost twice as effective at helping individuals lose weight than current weight-loss drugs, according to a Northwestern Medicine study.
Northwestern Medicine investigators have discovered a potential multi-faceted therapeutic target for preventing and treating the metabolic syndrome, according to a recent study.
Northwestern Medicine investigators have identified a potential combined targeted therapy approach for treating glioblastoma, according to a recent study published in the journal Scientific Reports.
Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.
A drug that demonstrated neuroprotective effect and slowed disease progression in animal models of Parkinson’s disease showed no symptomatic benefit in patients with the neurodegenerative disorder, according to results from a clinical trial led by Northwestern Medicine investigators.
An experimental drug called ezogabine reduced spinal neuron excitability in patients with ALS, according to a recent study.
A multi-disciplinary team of investigators led by Northwestern scientists have developed a novel wireless device that can constantly monitor pressure and temperature between the patient’s skin and prosthesis, improving overall comfort and wellbeing.
Vitrectomy surgery and intravitreal injections showed similar effectiveness in improving overall vision for patients with advanced diabetic retinopathy, according to results from a clinical trial published in JAMA.
A new study has found many physicians report being sexually harassed and personally attacked on social media on the basis of their religion, race or medical recommendations.